Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$7.68 USD
0.00 (0.00%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $7.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.68 USD
0.00 (0.00%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $7.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Zacks News
Acadia Healthcare (ACHC) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 9.09% and 0.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Acadia Healthcare, Pediatrix Medical, Tenet Healthcare and Discover Financial Services
by Zacks Equity Research
Acadia Healthcare, Pediatrix Medical, Tenet Healthcare and Discover Financial Services are part of Zacks Industry Outlook article.
Zacks.com featured highlights include Boot Barn, Canada Goose, Pediatrix Medical Group, Leap Therapeutics and Oncolytics Biotech
by Zacks Equity Research
Boot Barn, Canada Goose, Pediatrix Medical Group, Leap Therapeutics, and Oncolytics Biotech are part of Zacks Screen of the week article.
2 Top Hospital Stocks to Buy Despite Industry Headwinds
by Kaibalya Pravo Dey
Rising supplies expense, wages and benefits, and other operating costs are lowering margins for the Zacks Medical-Hospital industry players. However, Acadia Healthcare and Pediatrix Medical are poised to win big with recovering patient volumes.
Ride on Rising P/E Investing With These 5 Top-Ranked Stocks
by Sanghamitra Saha
Want to try an out-of-the-box approach? Tap Oncolytics Biotech (ONCY), Pediatrix Medical Group Inc (MD), Boot Barn (BOOT), Canada Goose (GOOS) and Leap Therapeutics (LPTX).
Why Pediatrix Medical (MD) is a Solid Bet for Your Portfolio
by Zacks Equity Research
Pediatrix Medical (MD) is expected to boost its services across maternal-fetal medicine, neonatology and obstetrics, plus 18 pediatric subspecialty offerings.
Will Mednax's (MD) New Name Pediatrix Medical be Beneficial?
by Zacks Equity Research
Mednax's (MD) name change is expected to take effect following the closing bell on Jul 1, 2022.
Why Acadia Healthcare (ACHC) Dips 1.6% Despite Q1 Earnings Beat
by Zacks Equity Research
Acadia Healthcare (ACHC) aims to add around 300 beds to its existing facilities in 2022.
Mednax (MD) Down 20% Despite Q1 Earnings Beat on Patient Volumes
by Zacks Equity Research
Mednax (MD) continues to anticipate revenues of $2 billion and adjusted EBITDA of at least $270 million for 2022.
Mednax (MD) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Mednax (MD) delivered earnings and revenue surprises of 22.22% and 1.75%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Universal Health Services (UHS) Q1 Earnings Miss Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of -12.96% and 2.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
HCA Healthcare (HCA) Q1 Earnings Miss Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of -3.51% and 1.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Universal Health (UHS) Stock Now
by Zacks Equity Research
Increased admissions at both of its operating segments, constant initiatives to bolster its care network and adequate cash generation abilities are likely to drive Universal Health (UHS).
Acadia Healthcare (ACHC) Up 10% in 3 Months: More Room to Run?
by Zacks Equity Research
Solid demand for behavioral healthcare services, multiple growth-related initiatives and a solid cash balance are driving Acadia Healthcare (ACHC).
Why Holding Humana (HUM) in Your Portfolio is a Prudent Move
by Zacks Equity Research
Banking on better membership and strategic initiatives, Humana (HUM) holds immense potential to reap benefits for investors.
Beyond MEME, 5 ETFs to Play Latest Reddit Craze
by Sanghamitra Saha
Meme stocks are those that hog attention of retail traders due to the hype surrounding them on online forums like Reddit. These stocks and ETFs could be played in order to tap the latest Reddit frenzy.
Humana (HUM) Taps Debt Market With Senior Note Pricing
by Zacks Equity Research
Humana (HUM) exhibits monetary discretion by pricing senior secured notes to procure funds.
Why Holding Centene (CNC) in Your Portfolio is a Smart Move
by Zacks Equity Research
Banking on a robust portfolio, buyouts and alliances plus contract wins, Centene (CNC) holds prospects to reap benefits for investors.
Why Holding Anthem (ANTM) in Your Portfolio is a Prudent Move
by Zacks Equity Research
Riding high on better membership, a robust portfolio and operational excellence, Anthem (ANTM) holds potential to reap benefits for investors.
Is it the Right Time to Add Mednax (MD) Stock to Your Kitty?
by Zacks Equity Research
Growing revenues, numerous acquisitions, diversified care network and adequate cash generation abilities are likely to continue driving Mednax (MD).
HCA Healthcare (HCA) Up 43.1% in a Year: Is More Upside Left?
by Zacks Equity Research
Growing revenues, numerous acquisitions and a sturdy financial standing continue to drive HCA Healthcare (HCA).
Tenet Healthcare (THC) Up 55% in a Year: Is More Upside Left?
by Zacks Equity Research
Growing revenues, strong performances exhibited by segments, numerous acquisitions and sturdy financial standing continue to drive Tenet Healthcare (THC).
Anthem (ANTM) to be Renamed as Elevance Health for Rebranding
by Zacks Equity Research
Anthem (ANTM) intends to rename itself as Elevance Health to solidify its position in the market that goes beyond traditional insurance products.
Should Value Investors Consider MEDNAX (MD) Stock Now?
by Zacks Equity Research
Is MEDNAX (MD) a great pick from the value investor's perspective right now? Read on to know more.
4 Stocks to Watch From the Flourishing Hospital Industry
by Kaibalya Pravo Dey
Rising patient volumes and the growing aging population are driving Zacks Medical-Hospital industry players' profits. HCA Healthcare, Universal Health, Tenet Healthcare and Mednax are poised to benefit from improving operating efficiency.